Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Regional De Marseille
Sponsor

Centre Hospitalier Regional De Marseille

France 80 Rue Brochier, 13005 Marseille, France

About the sponsor

Clinical research includes acute kidney injury and septic shock, with interest in renal recovery, organ failure, and critical care support in unstable patients.

  • Acute kidney injury
  • Septic shock
  • chronically occluded coronary artery

Cardiovascular and kidney-related studies also address antiplatelet treatment after coronary intervention and monitoring of cardiac function during immune checkpoint inhibitor therapy.

About Specializations

Centre Hospitalier Regional De Marseille runs clinical trials in conditions such as Crohn's disease, Neoplasm malignant, Septic shock, Gastrointestinal stromal tumour, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

23 clinical trials

Crohn's disease

Recruiting

Study on the Safety of Using Autologous Stromal Vascular Fraction Cells and Micrograft for Treating Hard-to-Heal Ano-Perineal Fistulas in Crohn's Disease Patients

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
  • Sponsor:Centre Hospitalier Regional De Marseille

Septic shock

Recruiting

Study on Adding Vasopressin to Treat Patients with Septic Shock

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Centre Hospitalier Regional De Marseille

Gastrointestinal stromal tumour

Recruiting

Study on the Effectiveness of Imatinib for Patients with Intermediate-Risk Gastrointestinal Stromal Tumor and High Genomic Grade Index

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Centre Hospitalier Regional De Marseille

Muscle spasticity

Recruiting

Study on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole
  • Sponsor:Centre Hospitalier Regional De Marseille

Osteoarthritis

Recruiting

Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Microfat
  • Sponsor:Centre Hospitalier Regional De Marseille

Hypoxic ischaemic encephalopathy neonatal

Recruiting

Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Autologous Cord Blood-Derived Mononuclear Cells
  • Sponsor:Centre Hospitalier Regional De Marseille

Diabetic foot

Recruiting

Treatment Study of Diabetic Foot Ulcers Using Autologous Stromal Vascular Fraction Cells for Patients with Non-healing Wounds

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
  • Sponsor:Centre Hospitalier Regional De Marseille

Vocal fold immobility

Recruiting

Study on the Effectiveness of Autologous Adipose-Derived Stromal Vascular Fraction Cells for Patients with Scarred Vocal Folds

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Regional De Marseille

Neoplasm malignant

Recruiting

Study on Heart Function Changes in Cancer Patients Treated with Nivolumab or Pembrolizumab

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Centre Hospitalier Regional De Marseille

Medulloblastoma recurrent+1

Recruiting

Study of Axitinib and Etoposide for Children and Young Adults with Refractory or Relapsing Medulloblastoma and Ependymoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Axitinib
  • Sponsor:Centre Hospitalier Regional De Marseille

Coronary artery disease

Recruiting

Study on Dual Antiplatelet Therapy Duration for Patients with Chronic Coronary Artery Blockage Using Clopidogrel and D,L-Lysine Acetylsalicylate

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Centre Hospitalier Regional De Marseille

Antibiotic prophylaxis

Recruiting

Study on Linezolid and Vancomycin for Preventing Surgical Site Infections in Patients Undergoing Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Centre Hospitalier Regional De Marseille

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.